Insider · CIK 0001379970
Steven C Gilman
Files at VCEL (Vericel Corp), SCYX (SCYNEXIS INC), AKBA (Akebia Therapeutics, Inc.). First filing Oct 18, 2024, latest Oct 18, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VCEL: Vericel Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | SCYX SCYNEXIS INC | AGrant or award Common stock | +23,000 | $0.00 | $0 | 70,000 | Jun 30, 2025 |
| Jun 26, 2025 | SCYX SCYNEXIS INC | AGrant or award Stock Optionderivative | +23,000 | $0.00 | $0 | 23,000 | Jun 30, 2025 |
| Jun 10, 2025 | AKBA Akebia Therapeutics, Inc. | AGrant or award Common Stock | +35,700 | $0.00 | $0 | 152,830 | Jun 11, 2025 |
| Jun 10, 2025 | AKBA Akebia Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +53,600 | $0.00 | $0 | 53,600 | Jun 11, 2025 |
| Oct 16, 2024 | VCEL Vericel Corp | MOption exercise Common Stock10b5-1 | +5,833 | $13.05 | $76k | 16,833 | Oct 18, 2024 |
| Oct 16, 2024 | VCEL Vericel Corp | SOpen-market sale Common Stock10b5-1 | -5,833 | $41.36 | $241k | 11,000 | Oct 18, 2024 |
| Oct 16, 2024 | VCEL Vericel Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +5,833 | $0.00 | $0 | 0 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.